Taylor Morrison Home Corporation
Taylor Morrison Home Corporation TMHC Peers
See (TMHC) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMHC | $60.01 | +1.81% | 6.02B | 6.99 | $8.59 | N/A |
| DHI | $125.75 | +1.91% | 38.63B | 9.53 | $13.19 | +1.20% |
| LEN-B | $108.48 | +1.84% | 29.58B | 7.92 | $13.70 | +1.79% |
| LEN | $111.88 | +1.61% | 29.38B | 8.17 | $13.70 | +1.79% |
| NVR | $7,360.80 | +1.58% | 21.52B | 15.00 | $490.60 | N/A |
| PHM | $104.41 | +1.60% | 20.93B | 7.37 | $14.16 | +0.80% |
| TOL | $107.23 | +0.80% | 10.66B | 7.39 | $14.51 | +0.88% |
| MTH | $69.04 | +1.98% | 4.96B | 6.99 | $9.88 | +2.25% |
| MDC | $62.98 | +0.05% | 4.73B | 11.91 | $5.29 | N/A |
| SKY | $80.51 | -1.39% | 4.61B | 28.45 | $2.83 | N/A |
Stock Comparison
TMHC vs DHI Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, DHI has a market cap of 38.63B. Regarding current trading prices, TMHC is priced at $60.01, while DHI trades at $125.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas DHI's P/E ratio is 9.53. In terms of profitability, TMHC's ROE is +0.16%, compared to DHI's ROE of +0.17%. Regarding short-term risk, TMHC is less volatile compared to DHI. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs LEN-B Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, LEN-B has a market cap of 29.58B. Regarding current trading prices, TMHC is priced at $60.01, while LEN-B trades at $108.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas LEN-B's P/E ratio is 7.92. In terms of profitability, TMHC's ROE is +0.16%, compared to LEN-B's ROE of +0.14%. Regarding short-term risk, TMHC is less volatile compared to LEN-B. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs LEN Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, LEN has a market cap of 29.38B. Regarding current trading prices, TMHC is priced at $60.01, while LEN trades at $111.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas LEN's P/E ratio is 8.17. In terms of profitability, TMHC's ROE is +0.16%, compared to LEN's ROE of +0.14%. Regarding short-term risk, TMHC is less volatile compared to LEN. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs NVR Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, NVR has a market cap of 21.52B. Regarding current trading prices, TMHC is priced at $60.01, while NVR trades at $7,360.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas NVR's P/E ratio is 15.00. In terms of profitability, TMHC's ROE is +0.16%, compared to NVR's ROE of +0.38%. Regarding short-term risk, TMHC is less volatile compared to NVR. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs PHM Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, PHM has a market cap of 20.93B. Regarding current trading prices, TMHC is priced at $60.01, while PHM trades at $104.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas PHM's P/E ratio is 7.37. In terms of profitability, TMHC's ROE is +0.16%, compared to PHM's ROE of +0.25%. Regarding short-term risk, TMHC is less volatile compared to PHM. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs TOL Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, TOL has a market cap of 10.66B. Regarding current trading prices, TMHC is priced at $60.01, while TOL trades at $107.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas TOL's P/E ratio is 7.39. In terms of profitability, TMHC's ROE is +0.16%, compared to TOL's ROE of +0.20%. Regarding short-term risk, TMHC is more volatile compared to TOL. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs MTH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, MTH has a market cap of 4.96B. Regarding current trading prices, TMHC is priced at $60.01, while MTH trades at $69.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas MTH's P/E ratio is 6.99. In terms of profitability, TMHC's ROE is +0.16%, compared to MTH's ROE of +0.14%. Regarding short-term risk, TMHC is less volatile compared to MTH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs MDC Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, MDC has a market cap of 4.73B. Regarding current trading prices, TMHC is priced at $60.01, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas MDC's P/E ratio is 11.91. In terms of profitability, TMHC's ROE is +0.16%, compared to MDC's ROE of +0.11%. Regarding short-term risk, TMHC is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs SKY Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, SKY has a market cap of 4.61B. Regarding current trading prices, TMHC is priced at $60.01, while SKY trades at $80.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas SKY's P/E ratio is 28.45. In terms of profitability, TMHC's ROE is +0.16%, compared to SKY's ROE of +0.15%. Regarding short-term risk, TMHC is less volatile compared to SKY. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs CVCO Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, CVCO has a market cap of 4.23B. Regarding current trading prices, TMHC is priced at $60.01, while CVCO trades at $528.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas CVCO's P/E ratio is 26.01. In terms of profitability, TMHC's ROE is +0.16%, compared to CVCO's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to CVCO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs KBH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, KBH has a market cap of 3.95B. Regarding current trading prices, TMHC is priced at $60.01, while KBH trades at $55.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas KBH's P/E ratio is 6.73. In terms of profitability, TMHC's ROE is +0.16%, compared to KBH's ROE of +0.15%. Regarding short-term risk, TMHC is more volatile compared to KBH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs MHO Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, MHO has a market cap of 3.01B. Regarding current trading prices, TMHC is priced at $60.01, while MHO trades at $112.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas MHO's P/E ratio is 5.94. In terms of profitability, TMHC's ROE is +0.16%, compared to MHO's ROE of +0.19%. Regarding short-term risk, TMHC is less volatile compared to MHO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs TPH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, TPH has a market cap of 2.90B. Regarding current trading prices, TMHC is priced at $60.01, while TPH trades at $31.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas TPH's P/E ratio is 6.62. In terms of profitability, TMHC's ROE is +0.16%, compared to TPH's ROE of +0.13%. Regarding short-term risk, TMHC is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs GRBK Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, GRBK has a market cap of 2.77B. Regarding current trading prices, TMHC is priced at $60.01, while GRBK trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas GRBK's P/E ratio is 7.60. In terms of profitability, TMHC's ROE is +0.16%, compared to GRBK's ROE of +0.24%. Regarding short-term risk, TMHC is less volatile compared to GRBK. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs DFH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, DFH has a market cap of 2.21B. Regarding current trading prices, TMHC is priced at $60.01, while DFH trades at $23.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas DFH's P/E ratio is 7.08. In terms of profitability, TMHC's ROE is +0.16%, compared to DFH's ROE of +0.25%. Regarding short-term risk, TMHC is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs CCS Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, CCS has a market cap of 1.73B. Regarding current trading prices, TMHC is priced at $60.01, while CCS trades at $56.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas CCS's P/E ratio is 5.85. In terms of profitability, TMHC's ROE is +0.16%, compared to CCS's ROE of +0.12%. Regarding short-term risk, TMHC is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs LGIH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, LGIH has a market cap of 1.36B. Regarding current trading prices, TMHC is priced at $60.01, while LGIH trades at $58.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas LGIH's P/E ratio is 7.51. In terms of profitability, TMHC's ROE is +0.16%, compared to LGIH's ROE of +0.09%. Regarding short-term risk, TMHC is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs GRBK-PA Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, GRBK-PA has a market cap of 962.43M. Regarding current trading prices, TMHC is priced at $60.01, while GRBK-PA trades at $21.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas GRBK-PA's P/E ratio is 4.97. In terms of profitability, TMHC's ROE is +0.16%, compared to GRBK-PA's ROE of +0.24%. Regarding short-term risk, TMHC is more volatile compared to GRBK-PA. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs HOV Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, HOV has a market cap of 714.91M. Regarding current trading prices, TMHC is priced at $60.01, while HOV trades at $111.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas HOV's P/E ratio is 3.44. In terms of profitability, TMHC's ROE is +0.16%, compared to HOV's ROE of +0.33%. Regarding short-term risk, TMHC is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs HOVNP Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, HOVNP has a market cap of 694.33M. Regarding current trading prices, TMHC is priced at $60.01, while HOVNP trades at $16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas HOVNP's P/E ratio is -6.62. In terms of profitability, TMHC's ROE is +0.16%, compared to HOVNP's ROE of +0.33%. Regarding short-term risk, TMHC is more volatile compared to HOVNP. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs BZH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, BZH has a market cap of 687.89M. Regarding current trading prices, TMHC is priced at $60.01, while BZH trades at $22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas BZH's P/E ratio is 7.35. In terms of profitability, TMHC's ROE is +0.16%, compared to BZH's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs LEGH Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, LEGH has a market cap of 569.18M. Regarding current trading prices, TMHC is priced at $60.01, while LEGH trades at $23.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas LEGH's P/E ratio is 10.22. In terms of profitability, TMHC's ROE is +0.16%, compared to LEGH's ROE of +0.12%. Regarding short-term risk, TMHC is less volatile compared to LEGH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs SIC Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, SIC has a market cap of 375.96M. Regarding current trading prices, TMHC is priced at $60.01, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas SIC's P/E ratio is 7.11. In terms of profitability, TMHC's ROE is +0.16%, compared to SIC's ROE of -0.06%. Regarding short-term risk, TMHC is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.
TMHC vs UHG Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, UHG has a market cap of 109.59M. Regarding current trading prices, TMHC is priced at $60.01, while UHG trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas UHG's P/E ratio is 2.08. In terms of profitability, TMHC's ROE is +0.16%, compared to UHG's ROE of +0.80%. Regarding short-term risk, TMHC is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.
TMHC vs SPHL Comparison
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6.02B. In comparison, SPHL has a market cap of 6.96M. Regarding current trading prices, TMHC is priced at $60.01, while SPHL trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 6.99, whereas SPHL's P/E ratio is -15.12. In terms of profitability, TMHC's ROE is +0.16%, compared to SPHL's ROE of N/A. Regarding short-term risk, TMHC is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.